Shares of the world's biggest drugmaker -- Pfizer -- dipped following the company's weekend announcement that it will halt development of a new heart disease remedy after unexpected trial results.
Pfizer officials were banking on the drug torcetrapib to be an important part of the company's future growth.
Copyright 2022 NPR. To see more, visit https://www.npr.org. 9(MDAzMjM2NDYzMDEyMzc1Njk5NjAxNzY3OQ001))
